Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Standard Blood Laboratory as a Clinical Support Tool to Distinguish between SARS-CoV-2 Positive and Negative Patients

Rainer Thell, Jascha Zimmermann, Marton Szell, Sabine Tomez, Philip Eisenburger, Moritz Haugk, Anna Kreil, Alexander Spiel, Amelie Blaschke, Anna Klicpera, Oskar Janata, Walter Krugluger, Christian Sebesta, Harald Herkner, Brenda Laky
doi: https://doi.org/10.1101/2020.10.23.20217844
Rainer Thell
1Wiener Gesundheitsverbund
2Department of Internal Medicine 2, Emergency Department, Klinik Donaustadt, Vienna, Austria
3Medical University Vienna, Austria
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: rainer.thell@meduniwien.ac.at
Jascha Zimmermann
4Sigmund Freud University, Medical School, Vienna, Austria
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marton Szell
1Wiener Gesundheitsverbund
2Department of Internal Medicine 2, Emergency Department, Klinik Donaustadt, Vienna, Austria
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sabine Tomez
1Wiener Gesundheitsverbund
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Philip Eisenburger
1Wiener Gesundheitsverbund
4Sigmund Freud University, Medical School, Vienna, Austria
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Moritz Haugk
1Wiener Gesundheitsverbund
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anna Kreil
1Wiener Gesundheitsverbund
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alexander Spiel
1Wiener Gesundheitsverbund
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Amelie Blaschke
1Wiener Gesundheitsverbund
2Department of Internal Medicine 2, Emergency Department, Klinik Donaustadt, Vienna, Austria
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anna Klicpera
1Wiener Gesundheitsverbund
2Department of Internal Medicine 2, Emergency Department, Klinik Donaustadt, Vienna, Austria
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Oskar Janata
1Wiener Gesundheitsverbund
2Department of Internal Medicine 2, Emergency Department, Klinik Donaustadt, Vienna, Austria
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Walter Krugluger
1Wiener Gesundheitsverbund
2Department of Internal Medicine 2, Emergency Department, Klinik Donaustadt, Vienna, Austria
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Christian Sebesta
1Wiener Gesundheitsverbund
2Department of Internal Medicine 2, Emergency Department, Klinik Donaustadt, Vienna, Austria
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Harald Herkner
3Medical University Vienna, Austria
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Brenda Laky
3Medical University Vienna, Austria
5Austrian Research Group for Regenerative and Orthopedic Medicine (AURROM), Vienna, Austria
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: brenda.laky@meduniwien.ac.at brenda.laky@aurrom.org
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

ABSTRACT

Background Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is current pandemic disease. Acute polymerase-chain-reaction is the gold standard test for this disease, is not available everywhere. Standard blood laboratory parameters may have diagnostic potential.

Methods We evaluated standard blood laboratory parameters of 655 COVID-19 patients suspected to be infected with SARS-CoV-2, who underwent PCR testing in one of five hospitals in Vienna, Austria. Additionally, clinical characteristics and 28-day outcome were obtained from medical records. We compared standard blood laboratory parameters, clinical characteristics, and outcomes between positive and negative PCR-tested patients and evaluated the ability of those parameters to distinguish between groups.

Results Of the 590 study patients including 276 females and 314 males, aged between 20 and 100 years, 208 were tested positive by means of PCR. Patients with positive compared to negative PCR-tests had significantly lower levels of leukocytes, basophils, eosinophils, monocytes, and thrombocytes; while significantly higher levels were detected with hemoglobin, C-reactive-protein (CRP), neutrophil-to-lymphocyte ratio (NLR), activated-partial-thromboplastin-time (aPTT), creatine-kinase (CK), lactate-dehydrogenase (LDH), alanine-aminotransferase (ALT), aspartate-aminotransferase (AST), and lipase. Our multivariate model correctly classified 83.9% of cases with a sensitivity of 78.4%, specificity of 87.3%, positive predictive value of 79.5%, and negative predictive value of 86.6%. Decreasing leucocytes and eosinophils and increasing hemoglobin and CRP were significantly associated with an increased likelihood of being COVID-19 positive tested.

Conclusions Our findings suggest that especially leucocytes, eosinophils, hemoglobin, and CRP are helpful to distinguish between COVID-19 positive and negative tested patients and that a certain blood pattern is able to predict PCR-results.

Summary Decreasing leucocytes and eosinophils and increasing hemoglobin and CRP were significantly associated with an increased likelihood of being COVID-19 positive tested. Each single parameter showed either a high sensitivity (leucocytes, eosinophils, CRP, monocytes, thrombocytes) or specificity (NLR, CK, ALT, lipase), or a sensitivity and specificity around 60% (Hb, LDH, AST).

Competing Interest Statement

The authors have declared no competing interest.

Clinical Trial

161/2020

Funding Statement

No funding

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

Ethics Commission of the City of Vienna

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

All data acquired can be reviewed by any editor as wished.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted October 27, 2020.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Standard Blood Laboratory as a Clinical Support Tool to Distinguish between SARS-CoV-2 Positive and Negative Patients
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Standard Blood Laboratory as a Clinical Support Tool to Distinguish between SARS-CoV-2 Positive and Negative Patients
Rainer Thell, Jascha Zimmermann, Marton Szell, Sabine Tomez, Philip Eisenburger, Moritz Haugk, Anna Kreil, Alexander Spiel, Amelie Blaschke, Anna Klicpera, Oskar Janata, Walter Krugluger, Christian Sebesta, Harald Herkner, Brenda Laky
medRxiv 2020.10.23.20217844; doi: https://doi.org/10.1101/2020.10.23.20217844
Digg logo Reddit logo Twitter logo Facebook logo Google logo LinkedIn logo Mendeley logo
Citation Tools
Standard Blood Laboratory as a Clinical Support Tool to Distinguish between SARS-CoV-2 Positive and Negative Patients
Rainer Thell, Jascha Zimmermann, Marton Szell, Sabine Tomez, Philip Eisenburger, Moritz Haugk, Anna Kreil, Alexander Spiel, Amelie Blaschke, Anna Klicpera, Oskar Janata, Walter Krugluger, Christian Sebesta, Harald Herkner, Brenda Laky
medRxiv 2020.10.23.20217844; doi: https://doi.org/10.1101/2020.10.23.20217844

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (161)
  • Allergy and Immunology (414)
  • Anesthesia (90)
  • Cardiovascular Medicine (857)
  • Dentistry and Oral Medicine (159)
  • Dermatology (97)
  • Emergency Medicine (248)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (393)
  • Epidemiology (8559)
  • Forensic Medicine (4)
  • Gastroenterology (383)
  • Genetic and Genomic Medicine (1749)
  • Geriatric Medicine (167)
  • Health Economics (372)
  • Health Informatics (1239)
  • Health Policy (620)
  • Health Systems and Quality Improvement (467)
  • Hematology (196)
  • HIV/AIDS (372)
  • Infectious Diseases (except HIV/AIDS) (10293)
  • Intensive Care and Critical Care Medicine (553)
  • Medical Education (192)
  • Medical Ethics (51)
  • Nephrology (211)
  • Neurology (1677)
  • Nursing (97)
  • Nutrition (250)
  • Obstetrics and Gynecology (326)
  • Occupational and Environmental Health (450)
  • Oncology (928)
  • Ophthalmology (263)
  • Orthopedics (101)
  • Otolaryngology (172)
  • Pain Medicine (113)
  • Palliative Medicine (40)
  • Pathology (252)
  • Pediatrics (534)
  • Pharmacology and Therapeutics (249)
  • Primary Care Research (207)
  • Psychiatry and Clinical Psychology (1765)
  • Public and Global Health (3835)
  • Radiology and Imaging (623)
  • Rehabilitation Medicine and Physical Therapy (320)
  • Respiratory Medicine (520)
  • Rheumatology (208)
  • Sexual and Reproductive Health (167)
  • Sports Medicine (158)
  • Surgery (190)
  • Toxicology (36)
  • Transplantation (101)
  • Urology (76)